Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin
Keywords: 
Gentamicin
Nanoparticles
Intracellular bacteria
Drug accumulation
Subcellular distribution
Issue Date: 
2012
Publisher: 
Oxford University Press
ISSN: 
0305-7453
Citation: 
Imbuluzqueta E, Lemaire S, Gamazo C, Elizondo E, Ventosa N, Veciana J, et al. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin. J Antimicrob Chemother 2012 Sep;67(9):2158-2164.
Abstract
OBJECTIVES: The aim of this study was to investigate different hydrophobic gentamicin formulations [gentamicin-bis(2-ethylhexyl) sulfosuccinate (GEN-AOT), microstructured GEN-AOT (PCA GEN-AOT) and GEN-AOT-loaded poly(lactide-co-glycolide) acid (PLGA) nanoparticles (NPs)] in view of improving its therapeutic index against intracellular bacteria. The intracellular accumulation, subcellular distribution and intracellular activity of GEN-AOT and NPs in different monocytic-macrophagic cell lines were studied. METHODS: Human THP-1 and murine J774 phagocytic cells were incubated with GEN-AOT formulations at relevant extracellular concentrations [from 1× MIC to 18 mg/L (human C(max))], and their intracellular accumulation, subcellular distribution and toxicity were evaluated and compared with those of conventional unmodified gentamicin. Intracellular activity of the formulations was determined against bacteria showing different subcellular localizations, namely Staphylococcus aureus (phagolysosomes) and Listeria monocytogenes (cytosol). RESULTS: GEN-AOT formulations accumulated 2-fold (GEN-AOT) to 8-fold (GEN-AOT NPs) more than gentamicin in phagocytic cells, with a predominant subcellular localization in the soluble fraction (cytosol) and with no significant cellular toxicity. NP formulations allowed gentamicin to exert its intracellular activity after shorter incubation times and/or at lower concentrations. With an extracellular concentration of 10× MIC, a 1 log(10) decrease in S. aureus intracellular inoculum was obtained after 12 h instead of 24 h for NPs versus free gentamicin, and a static effect was observed against L. monocytogenes at 24 h with NPs, while free gentamicin was ineffective. CONCLUSIONS: GEN-AOT formulations yielded a high cellular accumulation, especially in the cytosol, which resulted in improved efficacy against both intracellular S. aureus and L. monocytogenes.

Files in This Item:
Thumbnail
File
Imbuluzqueta-et-al-Manuscript-JAC-2011-1250R1.pdf
Description
Size
483.19 kB
Format
Adobe PDF
Thumbnail
File
Figure1-JAC-2011-1250R1.pdf
Description
Size
209.21 kB
Format
Adobe PDF
Thumbnail
File
Figure2-JAC-2011-1250R1.pdf
Description
Size
109.92 kB
Format
Adobe PDF
Thumbnail
File
Figure3-JAC-2011-1250R1.pdf
Description
Size
344.73 kB
Format
Adobe PDF
Thumbnail
File
FigureS1-JAC-2011-1250R1.pdf
Description
Size
128.98 kB
Format
Adobe PDF
Thumbnail
File
FigureS2-JAC-2011-1250R1.pdf
Description
Size
117.38 kB
Format
Adobe PDF
Thumbnail
File
FigureS3-JAC-2011-1250R1.pdf
Description
Size
58.67 kB
Format
Adobe PDF
Thumbnail
File
Table S1.pdf
Description
Size
25.5 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.